These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 30662405)

  • 101. Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines.
    Irie N; Mizoguchi K; Warita T; Nakano M; Sasaki K; Tashiro J; Osaki T; Ishikawa T; Oltvai ZN; Warita K
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540310
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells.
    Ortiz N; Delgado-Carazo JC; Díaz C
    Clin Exp Gastroenterol; 2021; 14():217-228. PubMed ID: 34103960
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Statins and endocrine resistance in breast cancer.
    Hyder T; Marti JLG; Nasrazadani A; Brufsky AM
    Cancer Drug Resist; 2021; 4(2):356-364. PubMed ID: 35582035
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Inhibition of the 3-hydroxy-3-methyl-glutaryl-CoA reductase diminishes the survival and size of chondrocytes during orofacial morphogenesis in zebrafish.
    Signore IA; Palma K; Soto G; Sepúlveda S; Suazo J; Aránguiz M; Colombo A
    Orthod Craniofac Res; 2023 Aug; 26(3):378-386. PubMed ID: 36320166
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins.
    Roy M; Kung HJ; Ghosh PM
    Am J Cancer Res; 2011; 1(4):542-61. PubMed ID: 21984972
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Novel applications of statins for bone regeneration.
    Shah SR; Werlang CA; Kasper FK; Mikos AG
    Natl Sci Rev; 2015 Mar; 2(1):85-99. PubMed ID: 26543666
    [TBL] [Abstract][Full Text] [Related]  

  • 107. p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.
    Centonze G; Natalini D; Grasso S; Morellato A; Salemme V; Piccolantonio A; D'Attanasio G; Savino A; Bianciotto OT; Fragomeni M; Scavuzzo A; Poncina M; Nigrelli F; De Gregorio M; Poli V; Arina P; Taverna D; Kopecka J; Dupont S; Turco E; Riganti C; Defilippi P
    Cell Death Dis; 2023 Dec; 14(12):849. PubMed ID: 38123597
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Decoding the crosstalk between mevalonate metabolism and T cell function.
    Kennewick KT; Bensinger SJ
    Immunol Rev; 2023 Aug; 317(1):71-94. PubMed ID: 36999733
    [TBL] [Abstract][Full Text] [Related]  

  • 109. HMGCR positively regulated the growth and migration of glioblastoma cells.
    Qiu Z; Yuan W; Chen T; Zhou C; Liu C; Huang Y; Han D; Huang Q
    Gene; 2016 Jan; 576(1 Pt 1):22-7. PubMed ID: 26432005
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effect of pH on structural dynamics of HMG-CoA reductase and binding affinity to β-sitosterol.
    Fatoki TH
    J Biomol Struct Dyn; 2023 Jul; 41(10):4398-4404. PubMed ID: 35470784
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The Innovative Potential of Statins in Cancer: New Targets for New Therapies.
    Di Bello E; Zwergel C; Mai A; Valente S
    Front Chem; 2020; 8():516. PubMed ID: 32626692
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The Statin Target Hmgcr Regulates Energy Metabolism and Food Intake through Central Mechanisms.
    Williams MJ; Alsehli AM; Gartner SN; Clemensson LE; Liao S; Eriksson A; Isgrove K; Thelander L; Khan Z; Itskov PM; Moulin TC; Ambrosi V; Al-Sabri MH; Lagunas-Rangel FA; Olszewski PK; Schiöth HB
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326421
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Statins and cancers.
    Stryjkowska-Góra A; Karczmarek-Borowska B; Góra T; Krawczak K
    Contemp Oncol (Pozn); 2015; 19(3):167-75. PubMed ID: 26557755
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53.
    Borini Etichetti CM; Arel Zalazar E; Cocordano N; Girardini J
    Front Oncol; 2020; 10():595034. PubMed ID: 33224889
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy.
    Pereira M; Matuszewska K; Glogova A; Petrik J
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884561
    [TBL] [Abstract][Full Text] [Related]  

  • 116. HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis.
    Zhong Z; Feng X; Su G; Du L; Liao W; Liu S; Li F; Zuo X; Yang P
    Front Cell Dev Biol; 2021; 9():731072. PubMed ID: 34692687
    [TBL] [Abstract][Full Text] [Related]  

  • 117. AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
    Tewari DN; Biswas A; Chakrabarti AK; Dutta S
    Virology; 2023 Oct; 587():109875. PubMed ID: 37703797
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA.
    Du X; Ou Y; Zhang M; Li K; Huang W; Jiang D
    Genes Dis; 2022 May; 9(3):741-752. PubMed ID: 35782968
    [TBL] [Abstract][Full Text] [Related]  

  • 119. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ.
    Miyajima C; Hayakawa Y; Inoue Y; Nagasaka M; Hayashi H
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015162
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.
    Ampuero J; Romero-Gomez M
    World J Hepatol; 2015 May; 7(8):1105-11. PubMed ID: 26052399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.